Maurice - i'm still not aware of any SNSS presentation at ASCO - i don't think there is one for vosaroxin. There is a Millennium poster about MLN2480 - but that's it - and that's a non-event since the poster for that compound only included safety data and no meaningful efficacy data, and that compound is for melanoma which is now becoming a crowded field with the recent positive data from Merck and BMS.
Thanks jj. I thought there was going to be some announcements, at least what I heard from Eric when he spoke at a conference late last month. I guess I was wrong there. He clearly said that there would be some new information in "10 days" on the LI-1 Phase 1 results. Maybe it is me jj.
Sorry about the confusion. I know that they had a poster on the pan-RAF inhibitor (Millennium) MLN2480.